Published in Brain on October 21, 2003
Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull (2009) 1.51
Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia. Brain (2015) 1.42
First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry (2006) 1.39
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study. Psychol Med (2011) 1.25
Altered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks. Neuroimage (2012) 1.18
Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period. Biol Psychiatry (2010) 1.10
Neurological soft signs in schizophrenia: a meta-analysis. Schizophr Bull (2009) 1.10
Neurobiological correlates of violent behavior among persons with schizophrenia. Schizophr Bull (2005) 1.06
Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology (2012) 1.04
Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm (Vienna) (2005) 1.02
Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr Bull (2013) 1.00
Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design. PLoS One (2009) 0.98
Neurological soft signs are not "soft" in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull (2013) 0.97
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res (2008) 0.97
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychol Med (2010) 0.96
Fronto-temporal dysfunction in schizophrenia: A selective review. Indian J Psychiatry (2009) 0.96
Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr Res (2010) 0.93
Finding behavioral and network indicators of brain vulnerability. Front Hum Neurosci (2012) 0.91
Childhood motor coordination and adult schizophrenia spectrum disorders. Am J Psychiatry (2009) 0.91
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome. Front Psychiatry (2014) 0.86
Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers. Compr Psychiatry (2007) 0.85
Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr Bull (2012) 0.85
Neurological abnormalities and neurocognitive functions in healthy elder people: a structural equation modeling analysis. Behav Brain Funct (2011) 0.82
Neurological soft signs in persons with amnestic mild cognitive impairment and the relationships to neuropsychological functions. Behav Brain Funct (2012) 0.80
Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology. Schizophr Res (2008) 0.80
Neurological soft signs in aging, mild cognitive impairment, and Alzheimer's disease - the impact of cognitive decline and cognitive reserve. Front Psychiatry (2015) 0.79
Sensory and motor secondary symptoms as indicators of brain vulnerability. J Neurodev Disord (2013) 0.78
Cortico-cerebellar functional connectivity and sequencing of movements in schizophrenia. BMC Psychiatry (2012) 0.78
Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis. Schizophr Res (2013) 0.78
Neurological soft signs in schizophrenia - The past, the present and the future. Indian J Psychiatry (2012) 0.77
Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients. Eur Arch Psychiatry Clin Neurosci (2006) 0.76
MRI study of the cavum septum pellucidum in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci (2009) 0.75
Neurological soft signs in individuals with pathological gambling. PLoS One (2013) 0.75
Prefrontal cortex connectivity dysfunction in performing the Fist-Edge-Palm task in patients with first-episode schizophrenia and non-psychotic first-degree relatives. Neuroimage Clin (2015) 0.75
Clinical Utility and Lifespan Profiling of Neurological Soft Signs in Schizophrenia Spectrum Disorders. Schizophr Bull (2015) 0.75
Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study. Psychopharmacol Bull (2016) 0.75
A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci (2006) 12.34
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Neurophysiological architecture of functional magnetic resonance images of human brain. Cereb Cortex (2005) 7.87
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Pesticide poisoning in the developing world--a minimum pesticides list. Lancet (2002) 5.10
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Undirected graphs of frequency-dependent functional connectivity in whole brain networks. Philos Trans R Soc Lond B Biol Sci (2005) 3.11
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci U S A (2007) 2.78
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry (2004) 2.44
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res (2004) 2.30
Reducing acute poisoning in developing countries--options for restricting the availability of pesticides. Toxicology (2003) 2.27
Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain (2002) 2.26
The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev (2007) 2.25
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14
Fractional Gaussian noise, functional MRI and Alzheimer's disease. Neuroimage (2005) 2.13
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Phenomenology, science and the anthropology of the self: a new model for the aetiology of psychosis. Br J Psychiatry (2004) 2.03
A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord (2011) 2.03
Adolescents who were born very preterm have decreased brain volumes. Brain (2002) 1.97
Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain (2004) 1.97
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry (2010) 1.92
Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry (2007) 1.92
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry (2007) 1.91
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Wavelets and functional magnetic resonance imaging of the human brain. Neuroimage (2004) 1.84
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry (2005) 1.83
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res (2005) 1.79
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry (2013) 1.76
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Atypical neural self-representation in autism. Brain (2009) 1.73
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry (2007) 1.71
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry (2008) 1.70
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry (2009) 1.69
Shared neural circuits for mentalizing about the self and others. J Cogn Neurosci (2010) 1.67